TCL6 and breast cancer: Contrarily, low expression of the lncRNA T cell leukemia/lymphoma 6 (TCL6) in breast cancer has been associated with worse prognosis in progesterone receptor (PR)-negative patients, attributed in part to tumor immune-escape, via regulation of immune-related pathways such JAK/STAT cascades.